Elutia (ELUT) Change in Receivables (2019 - 2026)
Elutia recorded quarterly Change in Receivables of $334000.0 in Q1 2026, up 124.54% quarter-over-quarter from -$1.4 million in Q4 2025, and down 42.81% year-over-year from $584000.0 in Q1 2025.
Elutia's Change in Receivables history runs 8 years deep, the most recent figure standing at $334000.0 for Q1 2026.
- In Q1 2026, Change in Receivables fell 42.81% year-over-year to $334000.0; the TTM figure through Mar 2026 stood at -$334000.0 (up 69.24% YoY), while the FY2025 annual figure was -$84000.0, up 84.06% from the prior year.
- Change in Receivables came in at $334000.0 for Q1 2026 at Elutia, up from -$1.4 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $1.1 million in Q1 2024 to a low of -$1.4 million in Q3 2023.
- A 5-year average of -$14411.8 and a median of $243000.0 in 2023 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables jumped 3500.0% in 2023 and plunged 385.25% in 2024, its largest moves.
- Elutia's Change in Receivables stood at -$329000.0 in 2022, then jumped by 173.86% to $243000.0 in 2023, then plunged by 283.54% to -$446000.0 in 2024, then slumped by 205.16% to -$1.4 million in 2025, then surged by 124.54% to $334000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $334000.0, -$1.4 million, and $403000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | 334,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 334,000.00 |
| Mar 31, 2026 | 334,000.00 |
| Dec 31, 2025 | -1.36 Mn |
| Dec 31, 2025 | -1.36 Mn |
| Sep 30, 2025 | 403,000.00 |
| Sep 30, 2025 | 403,000.00 |
| Jun 30, 2025 | 290,000.00 |
| Jun 30, 2025 | 290,000.00 |
| Mar 31, 2025 | 584,000.00 |
| Mar 31, 2025 | 584,000.00 |
| Dec 31, 2024 | -446,000.00 |
| Dec 31, 2024 | -446,000.00 |
| Sep 30, 2024 | -336,000.00 |
| Sep 30, 2024 | -336,000.00 |
| Jun 30, 2024 | -888,000.00 |
| Jun 30, 2024 | -888,000.00 |
| Mar 31, 2024 | 1.14 Mn |
| Mar 31, 2024 | 1.14 Mn |
| Dec 31, 2023 | 243,000.00 |
| Dec 31, 2023 | 243,000.00 |
| Sep 30, 2023 | -1.37 Mn |
| Sep 30, 2023 | -1.37 Mn |
| Jun 30, 2023 | -183,000.00 |
| Jun 30, 2023 | -183,000.00 |
| Mar 31, 2023 | 504,000.00 |
| Mar 31, 2023 | 504,000.00 |
| Dec 31, 2022 | -329,000.00 |
| Dec 31, 2022 | -329,000.00 |
| Sep 30, 2022 | 513,000.00 |
| Sep 30, 2022 | 513,000.00 |
| Jun 30, 2022 | 636,000.00 |
| Jun 30, 2022 | 636,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 477,000.00 |
| Dec 31, 2021 | 477,000.00 |
| Sep 30, 2021 | -2.23 Mn |
| Sep 30, 2021 | -2.23 Mn |
| Jun 30, 2021 | -1.01 Mn |
| Jun 30, 2021 | -1.01 Mn |
| Mar 31, 2021 | 1.60 Mn |
| Mar 31, 2021 | 1.60 Mn |
| Dec 31, 2020 | 70,000.00 |
| Dec 31, 2020 | 70,000.00 |
| Sep 30, 2020 | 1.23 Mn |
| Sep 30, 2020 | 1.23 Mn |
| Jun 30, 2020 | 240,000.00 |
| Jun 30, 2020 | 240,000.00 |
| Mar 31, 2020 | -1.60 Mn |
| Mar 31, 2020 | -1.60 Mn |
| Dec 31, 2019 | 725,000.00 |
| Dec 31, 2019 | 725,000.00 |